Last update May 13, 2019

Lauromacrogol 400

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

A mixture of macrogol ethers. An anionic surfactant detergent with sclerosing properties on varicose veins.
Administration by local injections in the vein to be sclerosed.
It contains 5% alcohol.

Since the last update we have not found any published data on its excretion in breast milk.

After local injections, low plasma levels have been detected in some patients (FDA 2010). Its moderately high molecular weight, large volume of distribution and short half-life (AEMPS 2017, FDA 2010) would hinder transfer into breastmilk.

Several experts believe that the use of this medication is probably compatible during breastfeeding (Briggs 2017, Hale 2017 p784).

Due to the lack of accurate pharmacokinetic data and given that after 5 half-lives of elimination (5 T½), 97% of a substance is eliminated from the body (Anderson 2016), it may be prudent, in order to minimize any possible exposure, to stop breastfeeding between 7 - 8 hours after the last sclerosing injection. However, the manufacturer advises a waiting period of 2 to 3 days (AEMPS 2017) which seems excessive since it is not based on the pharmacokinetics of the product.


See below the information of this related product:

Alternatives

We do not have alternatives for Lauromacrogol 400.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Lauromacrogol 400 is also known as Macrogol Lauril Ether. Here it is a list of alternative known names::


Lauromacrogol 400 in other languages or writings:

Pharmacokinetics

Variable Value Unit
Molecular weight 583 (400 - 600) daltons
VD 0.26 - 1.2 l/Kg
pKa 6.5 -
0.9 - 1.5 hours

References

  1. AEMPS-CFK&Co. Lauromacrogol(Etoxisclerol). Ficha técnica. 2017 Full text (in our servers)
  2. Hale TW, Rowe HE. Medications & Mothers' Milk. A Manual of Lactation Pharmacology. Springer Publishing Company. 2017
  3. Anderson PO. Cancer Chemotherapy. Breastfeed Med. 2016 May;11:164-5. Abstract Full text (link to original source) Full text (in our servers)
  4. Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Wolters Kluwer Health. Tenth edition (acces on line) 2015
  5. FDA-CFKCo Polidocanol (Asclera). Drug Summary. 2010 Full text (in our servers)

Total visits

6,685

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM